Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 3Breast 3Thoracic 1

Conditions

Neoplasms 9Neoplasm Metastasis 3

Interventions

pembrolizumab 34Specimen Handling 26Magnetic Resonance Spectroscopy 26Radiosurgery 25Biopsy 25Gemcitabine 22Nivolumab 21Paclitaxel 18Carboplatin 16Bevacizumab 15Trastuzumab 14Everolimus 12Radiotherapy 11Irinotecan 11trastuzumab deruxtecan 10atezolizumab 10Erlotinib Hydrochloride 10Docetaxel 10Cetuximab 10Capecitabine 10Albumin-Bound Paclitaxel 10130-nm albumin-bound paclitaxel 10Sorafenib 9Ipilimumab 9Cisplatin 9Taxes 8Standard of Care 8Oxaliplatin 8Drug Therapy 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Positron Emission Tomography Computed Tomography × Tumor-Agnostic × Clear all
NCT06055764 2023-09-28

Role of FDG PET/CT in Patients With Metastasis of Unknown Origin

Assiut University

Not yet recruiting
73 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04499365 2020-09-09

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Unknown
500 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04525612 2020-09-09

68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer

First Affiliated Hospital of Fujian Medical University

Phase EARLY_PHASE1 Unknown
100 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡